News & Updates | Solve FSHD

10/15/22Press Release

SOLVE FSHD Invests Up To US $10 Million in Vita Therapeutics

10/12/22Press Release

SOLVE FSHD Invests US $1 Million in miRecule to Accelerate Development of Best-in-Class Antibody-RNA Conjugate to Treat Facioscapulohumeral Muscular Dystrophy

09/22/22Press Release

SOLVE FSHD Invests US$3 Million in Altay Therapeutics

Learn about Altay Press Release

09/20/22News

SOLVE FSHD Provides Funding to n-Lorem for a Collaboration to Expand Understanding of FSHD2, a Rare Form of Muscular Dystrophy

06/08/22News

SOLVE FSHD Announces Appointment of Executive Director Dr. Eva Chin and Venture-Philanthropic Funding Structure

03/11/22Press Release

SOLVE FSHD is supporting the FSHD Clinical Trial Research Network (CTRN) through a donation of $2.8M to the FSHD Canada Foundation

03/09/22News

SOLVE FSHD Supports the FSHD Canada Foundation in Funding of US$1.2M in Multidisciplinary Biomarker Grants

03/09/22News

From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD